Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2313336
Max Phase: Preclinical
Molecular Formula: C35H42N4O12
Molecular Weight: 710.74
Molecule Type: Small molecule
Associated Items:
ID: ALA2313336
Max Phase: Preclinical
Molecular Formula: C35H42N4O12
Molecular Weight: 710.74
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: [N-]=[N+]=NCCCO[C@@H]1O[C@H](CO)[C@@H](O[C@@H]2O[C@H](CO)[C@H](O)[C@H](OCc3ccc(Oc4ccccc4)cc3)[C@H]2O)[C@H](O)[C@H]1NC(=O)c1ccccc1
Standard InChI: InChI=1S/C35H42N4O12/c36-39-37-16-7-17-46-34-27(38-33(45)22-8-3-1-4-9-22)29(43)31(26(19-41)50-34)51-35-30(44)32(28(42)25(18-40)49-35)47-20-21-12-14-24(15-13-21)48-23-10-5-2-6-11-23/h1-6,8-15,25-32,34-35,40-44H,7,16-20H2,(H,38,45)/t25-,26-,27-,28+,29-,30-,31-,32+,34-,35+/m1/s1
Standard InChI Key: DMKMBVXEHQBTGT-OKBDKMGCSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 710.74 | Molecular Weight (Monoisotopic): 710.2799 | AlogP: 1.78 | #Rotatable Bonds: 16 |
Polar Surface Area: 234.39 | Molecular Species: ACID | HBA: 13 | HBD: 6 |
#RO5 Violations: 3 | HBA (Lipinski): 16 | HBD (Lipinski): 6 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: -10.20 | CX Basic pKa: | CX LogP: 1.56 | CX LogD: 1.45 |
Aromatic Rings: 3 | Heavy Atoms: 51 | QED Weighted: 0.05 | Np Likeness Score: 0.65 |
1. van Hattum H, Branderhorst HM, Moret EE, Nilsson UJ, Leffler H, Pieters RJ.. (2013) Tuning the preference of thiodigalactoside- and lactosamine-based ligands to galectin-3 over galectin-1., 56 (3): [PMID:23281927] [10.1021/jm301677r] |
Source(1):